SONA Group Enters a New Stage of Strategic Growth

08/ 07/ 2025

SONA Group has announced the launch of a new phase in its strategic development, focused on transforming management approaches, accelerating international market expansion, and deepening its expertise across key business domains. This step marks the transition from a national market leader to an ambitious international ecosystem, with a strong emphasis on sustainability and innovation. Today, SONA Group unites companies operating in the pharmaceutical, service provision, distribution, and professional education sectors. Recognizing the challenges of today’s market, the leadership team has articulated a renewed vision, established during a recent strategic session. This vision centers on business scaling, sustainable growth, and managerial maturity. Key strategic initiatives include: Launching a modern corporate governance system Expanding the product portfolio within existing therapeutic areas Entering new product categories Expanding geographically into international markets Forming a unified executive team across SONA Group Centralizing operations of SONA-Pharm and SONA-Pharmexim to enhance operational efficiency These initiatives are designed not only to optimize internal processes but also to strengthen competitiveness in an increasingly dynamic regional landscape. At the heart of this transformation are people - attracting and nurturing talented professionals, fostering transparent governance, and building long-term partnerships with leading manufacturers, public institutions, and private sector organizations. “We believe that now is the ideal moment to redefine the scope of our operations. With a strong leadership team, a clear strategy, and confidence in our system, we are ready to transform not only the pharmaceutical market but also the quality of life in the countries where our products and services are present,” - says Ostap Kupnovytskyi, Founder of SONA Group. SONA Group remains committed to its long-term goal: to become the partner of choice in the pharmaceutical market by delivering sustainable innovations that have a tangible impact on people’s health and well-being.

SONA Group has announced the launch of a new phase in its strategic development, focused on transforming management approaches, accelerating international market expansion, and deepening its expertise across key business domains. This step marks the transition from a national market leader to an ambitious international ecosystem, with a strong emphasis on sustainability and innovation.

Today, SONA Group unites companies operating in the pharmaceutical, service provision, distribution, and professional education sectors. Recognizing the challenges of today’s market, the leadership team has articulated a renewed vision, established during a recent strategic session. This vision centers on business scaling, sustainable growth, and managerial maturity.

Key strategic initiatives include:

Launching a modern corporate governance system
Expanding the product portfolio within existing therapeutic areas
Entering new product categories
Expanding geographically into international markets
Forming a unified executive team across SONA Group
Centralizing operations of SONA-Pharm and SONA-Pharmexim to enhance operational efficiency

These initiatives are designed not only to optimize internal processes but also to strengthen competitiveness in an increasingly dynamic regional landscape. At the heart of this transformation are people – attracting and nurturing talented professionals, fostering transparent governance, and building long-term partnerships with leading manufacturers, public institutions, and private sector organizations.

“We believe that now is the ideal moment to redefine the scope of our operations. With a strong leadership team, a clear strategy, and confidence in our system, we are ready to transform not only the pharmaceutical market but also the quality of life in the countries where our products and services are present,” – says Ostap Kupnovytskyi, Founder of SONA Group.

SONA Group remains committed to its long-term goal: to become the partner of choice in the pharmaceutical market by delivering sustainable innovations that have a tangible impact on people’s health and well-being.